Synbiotics Decrease the Incidence of Septic Complications in Patients with Severe SIRS: A Preliminary Report

DOI PDF Web Site Web Site PubMed 12 Citations

Bibliographic Information

Published
2008-08-23
Rights Information
  • http://www.springer.com/tdm
DOI
  • 10.1007/s10620-008-0460-2
Publisher
Springer Science and Business Media LLC

Search this article

Description

The purpose of this study was to evaluate if synbiotic therapy can correct the deteriorated gut flora and environment in patients with severe systemic inflammatory response syndrome (SIRS). Twenty-nine SIRS patients, who fulfilled a serum C-reactive protein (CRP) level10 mg/dl, received synbiotics (Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides) (S group) and were compared with previous observations in 26 patients without synbiotics (NS group). Analysis of fecal flora confirmed that patients in the S group had significantly greater levels of beneficial Bifidobacterium, Lactobacillus, and total organic acids (particularly short-chain fatty acids) than those in the NS group. The incidence of infectious complications such as enteritis, pneumonia, and bacteremia was significantly lower in the S group than in the NS group. Synbiotics maintain the gut flora and environment and decrease the incidence of septic complications in patients with severe SIRS. Further randomized controlled study is necessary to determine the effects of synbiotics.

Journal

Citations (12)*help

See more

Keywords

Report a problem

Back to top